Cabozantinib in the Treatment of Advanced Renal Cell Carcinoma in Adults Following Prior Vascular Endothelial Growth Factor Targeted Therapy: Clinical Trial Evidence and Experience
Therapeutic Advances in Urology - United States
doi 10.1177/1756287217748867
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 9, 2018
Authors
Publisher
SAGE Publications